메뉴 건너뛰기




Volumn 371, Issue 23, 2014, Pages 2225-2226

Dual antiplatelet therapy after drug-eluting stents - How long to treat?

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLACEBO; PRASUGREL; ACETYLSALICYLIC ACID; PIPERAZINE DERIVATIVE; THIOPHENE DERIVATIVE; TICLOPIDINE;

EID: 84918792834     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1413297     Document Type: Editorial
Times cited : (17)

References (10)
  • 1
    • 84905644591 scopus 로고    scopus 로고
    • Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type
    • Camenzind E, Boersma E, Wijns W, et al. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type. Eur Heart J 2014; 35:1932-48.
    • (2014) Eur Heart J , vol.35 , pp. 1932-1948
    • Camenzind, E.1    Boersma, E.2    Wijns, W.3
  • 2
    • 84862858272 scopus 로고    scopus 로고
    • Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after xience v implantation: Results from the 8,061-patient xience v united states study
    • Naidu SS, Krucoff MW, Rutledge DR, et al. Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study. JACC Cardiovasc Interv 2012;5:626-35.
    • (2012) JACC Cardiovasc Interv , vol.5 , pp. 626-635
    • Naidu, S.S.1    Krucoff, M.W.2    Rutledge, D.R.3
  • 3
    • 84918772240 scopus 로고    scopus 로고
    • Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
    • Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014;371:2155-66.
    • (2014) N Engl J Med , vol.371 , pp. 2155-2166
    • Mauri, L.1    Kereiakes, D.J.2    Yeh, R.W.3
  • 4
    • 84856452781 scopus 로고    scopus 로고
    • Six-month versus 12-month dual antiplatelet therapy after implantation of drugeluting stents: The efficacy of xience/promus versus cypher to reduce late loss after stenting (excellent) randomized, multicenter study
    • Gwon HC, Hahn JY, Park KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drugeluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 2012;125:505-13.
    • (2012) Circulation , vol.125 , pp. 505-513
    • Gwon, H.C.1    Hahn, J.Y.2    Park, K.W.3
  • 5
    • 84890373385 scopus 로고    scopus 로고
    • Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The optimize randomized trial
    • Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA 2013;310:2510-22.
    • (2013) JAMA , vol.310 , pp. 2510-2522
    • Feres, F.1    Costa, R.A.2    Abizaid, A.3
  • 6
    • 84867050148 scopus 로고    scopus 로고
    • A new strategy for discontinuation of dual antiplatelet therapy: The reset trial (real safety and efficacy of 3-month dual antiplatelet therapy following endeavor zotarolimus-eluting stent implantation)
    • Kim BK, Hong MK, Shin DH, et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol 2012;60:1340-8.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 1340-1348
    • Kim, B.K.1    Hong, M.K.2    Shin, D.H.3
  • 7
    • 84918810121 scopus 로고    scopus 로고
    • Second generation drug-eluting stent implantation followed by 6-versus 12-month dual antiplatelet therapy: The security randomized clinical trial
    • Colombo A, Chieffo A, Frasheri A, et al. Second generation drug-eluting stent implantation followed by 6-versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. J Am Coll Cardiol 2014;64:2086-97.
    • (2014) J Am Coll Cardiol , vol.64 , pp. 2086-2097
    • Colombo, A.1    Chieffo, A.2    Frasheri, A.3
  • 8
    • 84860135329 scopus 로고    scopus 로고
    • Short-versus longterm duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial
    • Valgimigli M, Campo G, Monti M, et al. Short-versus longterm duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 2012;125:2015-26.
    • (2012) Circulation , vol.125 , pp. 2015-2026
    • Valgimigli, M.1    Campo, G.2    Monti, M.3
  • 9
    • 84908060277 scopus 로고    scopus 로고
    • Shorter (?6 months) versus longer (?12 months) duration dual antiplatelet therapy after drug eluting stents: A meta-analysis of randomized clinical trials
    • April 18 Epub ahead of print
    • Pandit A, Giri S, Hakim FA, Fortuin FD. Shorter (?6 months) versus longer (?12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials. Catheter Cardiovasc Interv 2014 April 18 (Epub ahead of print).
    • (2014) Catheter Cardiovasc Interv
    • Pandit, A.1    Giri, S.2    Hakim, F.A.3    Fortuin, F.D.4
  • 10
    • 84903168112 scopus 로고    scopus 로고
    • Meta-analysis of randomized clinical trials comparing short-term versus longterm dual antiplatelet therapy following drug-eluting stents
    • El-Hayek G, Messerli F, Bangalore S, et al. Meta-analysis of randomized clinical trials comparing short-term versus longterm dual antiplatelet therapy following drug-eluting stents. Am J Cardiol 2014;114:236-42.
    • (2014) Am J Cardiol , vol.114 , pp. 236-242
    • El-Hayek, G.1    Messerli, F.2    Bangalore, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.